Skin fragility and blistering secondary to imatinib.
H
H
Reddy
H L
HL
Horne
Z
Z
Maung
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D001768:Blister / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012871:Skin Diseases / Q000139:chemically induced*
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate